"Latent Tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.
| Descriptor ID |
D055985
|
| MeSH Number(s) |
C01.252.410.040.552.846.122
|
| Concept/Terms |
Latent Tuberculosis- Latent Tuberculosis
- Latent Tuberculoses
- Tuberculoses, Latent
- Tuberculosis, Latent
- Latent Tuberculosis Infection
- Infection, Latent Tuberculosis
- Infections, Latent Tuberculosis
- Latent Tuberculosis Infections
- Tuberculosis Infection, Latent
- Tuberculosis Infections, Latent
|
Below are MeSH descriptors whose meaning is more general than "Latent Tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Latent Tuberculosis".
This graph shows the total number of publications written about "Latent Tuberculosis" by people in this website by year, and whether "Latent Tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 3 |
| 2020 | 2 | 0 | 2 |
| 2022 | 5 | 0 | 5 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Latent Tuberculosis" by people in Profiles.
-
Kim S, Thal R, Szkwarko D. Management of Latent Tuberculosis Infection. JAMA. 2023 02 07; 329(5):421-422.
-
Wilburn KM, Meade RK, Heckenberg EM, Dockterman J, Coers J, Sassetti CM, Olive AJ, Smith CM. Differential Requirement for IRGM Proteins during Tuberculosis Infection in Mice. Infect Immun. 2023 02 16; 91(2):e0051022.
-
Szkwarko D, Kim S, Carter EJ, Goldman RE. Primary care providers' and nurses' knowledge, attitudes, and skills regarding latent TB infection testing and treatment: A qualitative study from Rhode Island. PLoS One. 2022; 17(4):e0267029.
-
Magee MJ, Khakharia A, Gandhi NR, Day CL, Kornfeld H, Rhee MK, Phillips LS. Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection. Diabetes Care. 2022 04 01; 45(4):880-887.
-
Szkwarko D, Urbanowski ME, Thal R, Iyer P, Foley S, Randall LM, Bernardo J, Savageau JA, Cochran J. Expanding Latent Tuberculosis Infection Testing and Treatment in Massachusetts Primary Care Clinics via the ECHO Model. J Prim Care Community Health. 2022 Jan-Dec; 13:21501319221119942.
-
Verma S, Pacheco C, Carter EJ, Szkwarko D. Latent Tuberculosis Infection Treatment Outcomes in an At-Risk Underserved Population in Rhode Island. J Prim Care Community Health. 2022 Jan-Dec; 13:21501319221111106.
-
Bolduc P, Day PG, Behl-Chadha B, Karapanos M, Carson-Sasso V, Simpson EH, Hebert S. Community-Based HIV and Viral Hepatitis Fellowship Evaluation: Results from a Qualitative Study. J Prim Care Community Health. 2022 Jan-Dec; 13:21501319221138193.
-
Petrilli JD, Ara?jo LE, da Silva LS, Laus AC, M?ller I, Reis RM, Netto EM, Riley LW, Arruda S, Queiroz A. Whole blood mRNA expression-based targets to discriminate active tuberculosis from latent infection and other pulmonary diseases. Sci Rep. 2020 12 16; 10(1):22072.
-
Daniel VT, Blankenship KC, Daly RF, Tkachenko E, Morss-Walton PC, Levin NA. Low rate of conversion to positive tuberculosis status among patients with psoriasis on biologic therapies: A retrospective study from a US academic medical center. J Am Acad Dermatol. 2021 Mar; 84(3):830-833.
-
Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis. Sci Rep. 2019 12 03; 9(1):18217.